A. Eisenthal et al., EFFECT OF ALLOGENEIC-TUMOR CELLS, INTERLEUKIN-2 AND INTERLEUKIN-6, ONTHE GROWTH OF SUBCUTANEOUS SYNGENEIC TUMORS, Cancer immunology and immunotherapy, 37(4), 1993, pp. 233-239
In the present study we demonstrate the ability of allogeneic M3 tumor
cells to induce an antitumor response against the syngeneic tumor, wh
en injected locally together with syngeneic B16 melanoma cells. The re
placement of the allogeneic tumor cells with either syngeneic or allog
eneic splenocytes had no effect on the growth of the syngeneic tumor.
Systemic administration of both interleukin-2 (IL-2) and IL-6 did not
affect the antitumor response induced by allogeneic tumor cells. When
mice, previously injected with B 16 and M3 cells, were rechallenged su
bcutaneously with B 16 tumor cells at a different anatomical site, an
inhibitory effect in some, but not all, experiments was observed. Syst
emic injections of either IL-2 or IL-6 did not alter the antitumor eff
ects of the allogeneic and syngeneic tumor-cell mixtures. The signific
ance of our results in developing immunotherapy modalities based on ac
tive immunization with allogeneic tumor cells and selected cytokines i
s discussed.